common cancer is an agerelated diseaseslow aging is associated with reduced and delayed carcinogenesiscalorie restriction cr the most studied antiaging intervention prevents cancer by slowing down the aging processevidence is emerging that cr decelerates aging by deactivating mtor target of rapamycinrapamycin and other rapalogs suppress cellular senescence slow down aging and postpone agerelated diseases including cancerat the same time rapalogs are approved for certain cancer treatmentscan cancer prevention be explained by direct targeting of cancer cellsor does rapamycin prevent cancer indirectly through slowing down the aging processincreasing evidence points to the latter scenario